{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:31:04Z","timestamp":1792186264857,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejmech.2022.115012","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:41:00Z","timestamp":1670413260000},"page":"115012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Synthesis and in vitro antileishmanial activity of alkylene-linked nitrofurantoin-triazole hybrids"],"prefix":"10.1016","volume":"246","author":[{"given":"Nonkululeko H.","family":"Zuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Aucamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena D.","family":"Janse van Rensburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-0551","authenticated-orcid":false,"given":"David D.","family":"N'Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115012_bib1","author":"Leishmaniasis"},{"key":"10.1016\/j.ejmech.2022.115012_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijwd.2019.01.002","article-title":"Cutaneous leishmaniasis: a neglected disfiguring disease for women","volume":"5","author":"Bilgic-Temel","year":"2019","journal-title":"Int. J. Womens Dermatol."},{"key":"10.1016\/j.ejmech.2022.115012_bib3","first-page":"561","article-title":"Antiparasitic properties of curcumin: a review","volume":"3","author":"Cheraghipour","year":"2018","journal-title":"AIMS J."},{"key":"10.1016\/j.ejmech.2022.115012_bib4","article-title":"Synthesis, in vitro antileishmanial efficacy and hit\/lead identification of nitrofurantoin-triazole hybrids","volume":"n\/a","author":"Zuma","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.115012_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jac\/46.6.917","article-title":"Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG","volume":"46","author":"Murugasu-Oei","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.115012_bib6","first-page":"418","article-title":"Antibacterial properties and in vivo efficacy of a novel nitrofuran, IITR06144, against MDR pathogens","volume":"75","author":"Bhando","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.115012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105092","article-title":"An update on derivatisation and repurposing of clinical nitrofuran drugs","volume":"140","author":"Zuma","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2022.115012_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chembiol.2012.05.017","article-title":"ALDH2 mediates 5-nitrofuran activity in multiple species","volume":"19","author":"Zhou","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.115012_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1574-6976.2008.00107.x","article-title":"Reduction of polynitroaromatic compounds: the bacterial nitroreductases","volume":"32","author":"Rold\u00e1n","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.115012_bib10","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1111\/bph.13571","article-title":"Azoreductases in drug metabolism","volume":"174","author":"Ryan","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115012_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1289\/ehp.8564309","article-title":"Some reactions and properties of nitro radical-anions important in biology and medicine","volume":"64","author":"Wardman","year":"1985","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2022.115012_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-5793(85)80732-8","article-title":"Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels. Implications for a wider protective role","volume":"185","author":"Gutteridge","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2022.115012_bib13","series-title":"Basic Principles of Drug Discovery and Development","first-page":"499","article-title":"Case studies in drug discovery","author":"Blass","year":"2015"},{"key":"10.1016\/j.ejmech.2022.115012_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3821\/1913-701X-142.5.248","article-title":"A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment","volume":"142","author":"Bains","year":"2009","journal-title":"Can. Pharm. J."},{"key":"10.1016\/j.ejmech.2022.115012_bib15","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3762\/bjoc.17.154","article-title":"Synthesis and antimicrobial activity of 1H-1,2,3-triazole and carboxylate analogues of metronidazole","volume":"17","author":"Avula","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/molecules25040790","article-title":"Design, synthesis, and antimicrobial activities of 1,2,3-triazole glycoside clickamers","volume":"25","author":"El Malah","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115012_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113069","article-title":"Recent accomplishments on the synthetic\/biological facets of pharmacologically active 1H-1,2,3-triazoles","volume":"212","author":"Kumar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/molecules27010230","article-title":"Recent advances in bioactive flavonoid hybrids linked by 1,2,3-triazole ring obtained by Click chemistry","volume":"27","author":"Pereira","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115012_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2014.05.005","article-title":"Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation","volume":"81","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib21","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1002\/slct.201802002","article-title":"Potential antileishmanial activity of a triazole-based hybrid peptide against Leishmania major","volume":"3","author":"Maji","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2022.115012_bib22","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/jhet.3956","article-title":"Synthesis, antibacterial, and antioxidant activities of naphthyl-linked disubstituted 1,2,3-triazoles","volume":"57","author":"Kaushik","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00044-020-02553-0","article-title":"Synthesis and in vitro antimycobacterial and antileishmanial activities of hydroquinone-triazole hybrids","volume":"29","author":"Horn","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.115012_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1039\/C0MB00074D","article-title":"Impact of linker length on the activity of PROTACs","volume":"7","author":"Cyrus","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2022.115012_bib25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/ijms19041104","article-title":"Molecular consortia-various structural and synthetic concepts for more effective therapeutics synthesis","volume":"19","author":"Pawe\u0142czyk","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.115012_bib26","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1021\/jo3000095","article-title":"Copper-catalyzed azide\u2013alkyne cycloaddition reaction in water using cyclodextrin as a phase transfer catalyst","volume":"77","author":"Shin","year":"2012","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van de Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115012_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2022.115012_bib29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.115012_bib30","series-title":"Advances in Cancer Research","first-page":"133","article-title":"Chapter six - mass spectrometry imaging in oncology drug discovery","author":"Goodwin","year":"2017"},{"key":"10.1016\/j.ejmech.2022.115012_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115012_bib32","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000675","article-title":"Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds","volume":"4","author":"Siqueira-Neto","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib34","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib36","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/cid\/ciaa1236","article-title":"Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani","volume":"72","author":"Potvin","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib37","article-title":"A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP-1 human acute monocytic leukemia cell line","volume":"70","author":"Jain","year":"2012","journal-title":"JoVE"},{"key":"10.1016\/j.ejmech.2022.115012_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2022.115012_bib39","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1021\/jf501351r","article-title":"Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells","volume":"62","author":"Fu","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2022.115012_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/md15100329","article-title":"Marine-derived penicillium species as producers of cytotoxic metabolites","volume":"15","author":"Liu","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2022.115012_bib41","article-title":"Topical treatment for cutaneous leishmaniasis: dermato-pharmacokinetic lead optimization of benzoxaboroles","volume":"62","author":"Bocxlaer","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115012_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109690","article-title":"Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins","volume":"351","author":"Bortoleti","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2022.115012_bib43","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection","volume":"52","author":"Mookerjee Basu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115012_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cid\/ciy645","article-title":"Static vs cidal antibiotics","volume":"68","author":"Steigbigel","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004094","article-title":"Development and validation of a novel Leishmania donovani screening cascade for high-throughput screening using a novel axenic assay with high predictivity of leishmanicidal intracellular activity","volume":"9","author":"N\u00fchs","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001896","article-title":"Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign","volume":"6","author":"Sykes","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001932","article-title":"A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes","volume":"6","author":"De Rycker","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115012_bib48","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","first-page":"252","article-title":"19 - pharmacokinetics and pharmacodynamics of anti-infective agents","author":"Pai","year":"2015"},{"key":"10.1016\/j.ejmech.2022.115012_bib49","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/cid\/cix1127","article-title":"Busting the myth of \"static vs cidal\": a systemic literature review","volume":"66","author":"Wald-Dickler","year":"2018","journal-title":"Clin. Infect. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200914X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200914X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:50:13Z","timestamp":1759330213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342200914X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":49,"alternative-id":["S022352342200914X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115012","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro antileishmanial activity of alkylene-linked nitrofurantoin-triazole hybrids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115012"}}